Literature DB >> 24163085

MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma.

Kai Zhang1, Fang Tian, Yonggang Zhang, Qing Zhu, Na Xue, Huimin Zhu, Heng Wang, Xinjun Guo.   

Abstract

There is mounting evidence that metastasis-associated in colon cancer-1 (MACC1) plays pivotal roles in development and progression of many tumors, particularly in osteosarcoma (OS). However, its precise roles and molecular mechanisms remain to be delineated in OS. In the current study, we found that the levels of MACC1 mRNA and protein in four OS cell lines (MG-63, HOS, SaOS-2 and U2OS) were significantly higher than that in hFOB1.19 osteoblast (P < 0.05). The vector pcDNA-MACC1 contributed to the increase of MACC1 level in MG-63 cells, whereas MACC1 siRNA evoked the decrease of MACC1 level in U2OS cells. In addition, MACC1 downregualtion caused the inhibition of cell proliferation in vitro, colony formation, invasion and tumor growth in vivo, arrested cell cycle in G0/G1 phase and induced cell apoptosis in U2OS cells, and reversed effects were observed in MG-63 cells by MACC1 upregulation. Most notably, MACC1 depletion markedly inactivated Akt signaling pathway in U2OS cells, conversely, MACC1 upregulation evidently activated Akt signaling pathway in MG-63 cells. Collectively, our data presented herein suggest that biological implications triggered by MACC1 may be tightly associated with the status of Akt signaling pathway in OS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24163085     DOI: 10.1007/s13277-013-1335-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  63 in total

1.  An activated Notch1 signaling pathway inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma cell line EC9706.

Authors:  Zhaoming Lu; Hongtao Liu; Lexun Xue; Peirong Xu; Tianxiao Gong; Guiqin Hou
Journal:  Int J Oncol       Date:  2008-03       Impact factor: 5.650

Review 2.  Genomic imprinting and cancer.

Authors:  A C Ferguson-Smith; W Reik; M A Surani
Journal:  Cancer Surv       Date:  1990

Review 3.  Historical, current and future aspects of osteosarcoma treatment.

Authors:  S J Ham; H Schraffordt Koops; W T van der Graaf; J R van Horn; L Postma; H J Hoekstra
Journal:  Eur J Surg Oncol       Date:  1998-12       Impact factor: 4.424

4.  The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

Authors:  M P Link; A M Goorin; A W Miser; A A Green; C B Pratt; J B Belasco; J Pritchard; J S Malpas; A R Baker; J A Kirkpatrick
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

Review 5.  Primary bone osteosarcoma in the pediatric age: state of the art.

Authors:  Alessandra Longhi; Costantino Errani; Massimiliano De Paolis; Mario Mercuri; Gaetano Bacci
Journal:  Cancer Treat Rev       Date:  2006-07-24       Impact factor: 12.111

6.  Anti-tumoral effect of a celecoxib low dose on a model of human medullary thyroid cancer in nude mice.

Authors:  Virginie Quidville; Nadine Segond; Ali Tebbi; Regis Cohen; Annick Jullienne; Michel Lepoivre; Sylvie Lausson
Journal:  Thyroid       Date:  2009-06       Impact factor: 6.568

Review 7.  Prognostic value of cell-cycle regulation biomarkers in bladder cancer.

Authors:  Anirban P Mitra; Donna E Hansel; Richard J Cote
Journal:  Semin Oncol       Date:  2012-10       Impact factor: 4.929

8.  Target protein for Xklp2 (TPX2), a microtubule-related protein, contributes to malignant phenotype in bladder carcinoma.

Authors:  Liang Yan; Shenglei Li; Changbao Xu; Xinghua Zhao; Bin Hao; Huixiang Li; Baoping Qiao
Journal:  Tumour Biol       Date:  2013-07-20

9.  Primary osteosarcoma of bone. Clinicopathologic investigation of 243 cases, with necropsy studies in 54.

Authors:  G Uribe-Botero; W O Russell; W W Sutow; R G Martin
Journal:  Am J Clin Pathol       Date:  1977-05       Impact factor: 2.493

10.  Tumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway.

Authors:  Baocai Lu; Wenyu Di; Huimin Wang; Huimin Ma; Jinsong Li; Qunmei Zhang
Journal:  Tumour Biol       Date:  2012-07-18
View more
  15 in total

1.  Downregulation of MACC1 inhibits the viability, invasion and migration and induces apoptosis in esophageal carcinoma cells through the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B signaling pathway.

Authors:  Li-Qiang Qian; Xia-Qin Li; Peng-Hui Ye; Hao-Yuan Su; Gang Wang; Yan Liu; Gen-Hai Shen; Quan-Gen Gao
Journal:  Oncol Lett       Date:  2017-08-23       Impact factor: 2.967

2.  Downregulation of calbindin 1, a calcium-binding protein, reduces the proliferation of osteosarcoma cells.

Authors:  Zhengxiang Huang; Guojun Fan; Dongliang Wang
Journal:  Oncol Lett       Date:  2017-03-28       Impact factor: 2.967

3.  Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer.

Authors:  Zhiqiang Wang; Ming Cai; Yuan Weng; Fang Zhang; Dong Meng; Jun Song; Huan Zhou; Zongtao Xie
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-28       Impact factor: 4.553

4.  LKB1 suppresses proliferation and invasion of prostate cancer through hedgehog signaling pathway.

Authors:  Peiyuan Xu; Fei Cai; Xiaofei Liu; Lele Guo
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

5.  MACC1 overexpression and survival in solid tumors: a meta-analysis.

Authors:  Gang Wang; Zhixuan Fu; Dechuan Li
Journal:  Tumour Biol       Date:  2014-10-19

6.  MACC1-Induced Collective Migration Is Promoted by Proliferation Rather Than Single Cell Biomechanics.

Authors:  Tim Hohmann; Urszula Hohmann; Mathias Dahlmann; Dennis Kobelt; Ulrike Stein; Faramarz Dehghani
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

7.  MicroRNA-432 is downregulated in osteosarcoma and inhibits cell proliferation and invasion by directly targeting metastasis-associated in colon cancer-1.

Authors:  Dengkun Lv; Zhen Zhen; Defa Huang
Journal:  Exp Ther Med       Date:  2018-11-29       Impact factor: 2.447

Review 8.  Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II.

Authors:  Matej Horvat; Uroš Potočnik; Katja Repnik; Rajko Kavalar; Borut Štabuc
Journal:  Gastroenterol Res Pract       Date:  2016-01-14       Impact factor: 2.260

Review 9.  The potential therapeutic applications and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) in cancers.

Authors:  Ewa Katarzyna Kopczyńska
Journal:  Contemp Oncol (Pozn)       Date:  2016-09-05

10.  FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.

Authors:  Zhongming Huang; Junhua Li; Shaohua Du; Yanghua Tang; Ligang Huang; Luwei Xiao; Peijian Tong
Journal:  Oncotarget       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.